Additionally, levels of FOXP3 transcripts were increased with Treg EV treatment; myeloid-specific CD206 transcripts were also increased in Treg EV treated ALS mice compared with PBS treated mice. This evidence concerns the gene FOXP3 and amyotrophic lateral sclerosis.